CSB 2.008 Note
(3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to read:
CSB 2.008 Note
(mg) Prazepam;
CSB 2.008 Note
(4) Paragraph (hg) of s.
161.20 (2), Stats., is created to read:
CSB 2.008 Note
(hg) Midazolam;
CSB 2.008 Note
(5) Paragraph (mm) of s.
161.20 (2), Stats., is created to read:
CSB 2.008 Note
(mm) Quazepam;
CSB 2.008 Note
(6) Paragraph (km) of s.
161.18 (3), Stats., is created to read:
CSB 2.008 Note
(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.008 Note
(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.008 Note
(am) Alphaprodine;
CSB 2.008 Note
(8) Paragraph (a) of s.
161.16 (3), Stats., is created to read:
CSB 2.008 Note
(a) Alfentanil;
CSB 2.008 Note
(9) Paragraph (rg) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.008 Note
(10) Paragraph (vg) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.008 Note
(11) Paragraph (b) of s.
161.16 (10), Stats., is created to read:
CSB 2.008 Note
(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.008 Note
(12) Subsection
(2) of s.
161.14, Stats., is amended to read:
CSB 2.008 Note
(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.008 Note
(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.008 Note
(ag) Acetylmethadol;
CSB 2.008 Note
(14) Paragraph (a) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.008 Note
(15) Paragraph (cg) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(16) Paragraph (dg) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(17) Paragraph (rj) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(18) Paragraph (tg) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.008 Note
(19) Paragraph (xm) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.008 History
History:
Cr.
Register, February, 1988, No. 386, eff. 3-1-88.
CSB 2.008 Note
CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.008 History
History:
Cr.
Register, July, 1989, No. 403, eff. 8-1-89.
CSB 2.008 Note
CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection
(1) of s.
161.14, Stats., is amended to read:
CSB 2.008 Note
(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.008 Note
(2) Paragraph (a) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.008 Note
(3) Paragraph (er) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(4) Paragraph (rg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.008 Note
(5) Paragraph (qs) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(6) Paragraph (tg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.008 Note
(7) Paragraph (vg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.008 Note
(8) Paragraph (xm) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.008 Note
(9) Paragraph (cd) of s.
161.14 (2), Stats., is created to read:
CSB 2.008 Note
(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.008 Note
(10) Paragraph (e) of s.
161.14 (3), Stats., is amended to read:
CSB 2.008 Note
(e) Codeine-N-oxide;
CSB 2.008 Note
(11) Paragraph (j) of s.
161.14 (3), Stats., is amended to read:
CSB 2.008 Note
(j) Etorphine, except its hydrochloride salts;
CSB 2.008 Note
(12) Paragraph (s) of s.
161.14 (3), Stats., is amended to read:
CSB 2.008 Note
(s) Morphine-N-oxide;
CSB 2.008 Note
(13) Paragraph (a) of s.
161.14 (4), Stats., is amended to read:
CSB 2.008 Note
(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA";
CSB 2.008 Note
(14) Paragraph (b) of s.
161.14 (4), Stats., is amended to read:
CSB 2.008 Note
(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.008 Note
(15) Paragraph (c) of s.
161.14 (4), Stats., is amended to read:
CSB 2.008 Note
(c) 3,4,5-trimethoxyamphetamine;
CSB 2.008 Note
(16) Paragraph (ag) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE";
CSB 2.008 Note
(17) Paragraph (ar) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.008 Note
(18) Paragraph (u) of s.
161.14 (4), Stats., is amended to read:
CSB 2.008 Note
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.008 Note
(19) Paragraph (ud) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.008 Note
(20) Paragraph (ur) of s.
161.14 (4), Stats., is amended to read:
CSB 2.008 Note
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.008 Note
(21) Paragraph (d) of s.
161.14 (7), Stats., is created to read:
CSB 2.008 Note
(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.008 Note
(22) Paragraph (e) of s.
161.14 (7), Stats., is created to read:
CSB 2.008 Note
(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.008 Note
(23) Paragraph (L) of s.
161.14 (7), Stats., is created to read:
CSB 2.008 Note
(L) methcathinone, including its salts and salts of isomers.
CSB 2.008 Note
(24) Subdivision 4m of s.
161.16 (2) (a), Stats., is created to read:
CSB 2.008 Note
4m. Dihydrocodeine;
CSB 2.008 Note
(25) Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.008 Note
(26) Paragraph (am) of s.
161.16 (7), Stats., is created to read:
CSB 2.008 Note
(am) Glutethimide;